Avascular Necrosis clinical trials
16 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Physica System Total Knee Replacement Registry Study
- Deep Phenotyping Gait Deficits in Orthopedic Manifestations of Pediatric Cancer Patients
- Perform Humeral System Study
- Persona Revision Knee System Outcomes
- MDR - PMCF Study for Taperloc Complete Stems
- Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert
- Survivorship and Effectiveness of the Ortho Development® Entrada™ Hip System for Total Hip Arthroplasty
- Post Market Clinical Follow-Up Study for PROFEMUR® Preserve Classic Femoral Stem
- Post Market Clinical Follow-Up Study- EVOLUTION® Revision CCK
- G7 Freedom Constrained Vivacit-E Liners
- G7 Dual Mobility With Vivacit-E or Longevity PMCF
- Tornier HRS (Humeral Reconstruction System) Study (REVIVE)
- MDR - PMCF Study for RingLoc Bipolar Acetabular Cup and Endo II Femoral Heads
- MDR - Comprehensive Primary/Micro Stem & Versa-Dial Ti Humeral Head
- Persona SoluTion PPS Femur PMCF
- Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Avascular Necrosis” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.